Fucoxanthin (all-trans-Fucoxanthin)
(Synonyms: 岩藻黄质; all-trans-Fucoxanthin) 目录号 : GC31364Fucoxanthin (all-trans-Fucoxanthin)是一种天然存在的类胡萝卜素,广泛分布于食用棕色海藻和硅藻中。
Cas No.:3351-86-8
Sample solution is provided at 25 µL, 10mM.
Fucoxanthin (all-trans-Fucoxanthin) is a naturally occurring carotenoid widely distributed in edible brown seaweed and diatoms[1]. Fucoxanthin is highly unsaturated, its molecular structure is unstable and very active. Fucoxanthin has four isomers, namely all-trans Fucoxanthin (the main isomer in the natural environment), 9′-cis Fucoxanthin, 13-cis Fucoxanthin, and 13′-cis Fucoxanthin[2]. Fucoxanthin can be used in research on obesity, anti-diabetes, antioxidants, inflammation, and cancer[3]. Fucoxanthin can effectively inhibit the activity of Mycobacterium tuberculosis aromatic amine N-acetyltransferase (TBNAT), with an IC50 value of 4.8µM[4].
In vitro, treatment of B16-F10 cells with Fucoxanthin (0-30μM) for 24h inhibited cell invasion, migration and adhesion in a dose-dependent manner, and inhibited the expression of transfer factors MMP-9, CD44 and CXCR4[5]. Treatment of cervical cancer HeLa and SiHa cells with Fucoxanthin (0-25µM) for 24h inhibited cell proliferation and induced cell cycle arrest at the G0/G1 phase[6]. Treatment of RAW264.7 cells with Fucoxanthin (0-100µg/mL) for 24h inhibited the expression of intracellular TNF-α, PGE2, iNOS and COX-2 proteins in a dose-dependent manner[7].
In vivo, oral administration of Fucoxanthin (25, 50mg/kg) to mice with cadmium chloride-induced renal injury for 14 days promoted the recovery of renal function, renal cell microstructure and ultrastructure, significantly reduced blood urea nitrogen (BUN), kidney injury marker 1 (KIM1) and neutrophil gelatinase-associated lipocalin (NGAL) levels in mice, and increased peroxidase (POD), superoxide dismutase (SOD), catalase (CAT) and ascorbate peroxidase (APX) levels[8].
References:
[1] Din N A S, Mohd Alayudin A S, Sofian-Seng N S, et al. Brown algae as functional food source of fucoxanthin: A review[J]. Foods, 2022, 11(15): 2235.
[2] Pajot A, Hao Huynh G, Picot L, et al. Fucoxanthin from algae to human, an extraordinary bioresource: Insights and advances in up and downstream processes[J]. Marine drugs, 2022, 20(4): 222.
[3] Miyashita K, Beppu F, Hosokawa M, et al. Nutraceutical characteristics of the brown seaweed carotenoid fucoxanthin[J]. Archives of biochemistry and biophysics, 2020, 686: 108364.
[4] Šudomová M, Shariati M A, Echeverría J, et al. A microbiological, toxicological, and biochemical study of the effects of fucoxanthin, a marine carotenoid, on Mycobacterium tuberculosis and the enzymes implicated in its cell wall: A link between mycobacterial infection and autoimmune diseases[J]. Marine drugs, 2019, 17(11): 641.
[5] Chung T W, Choi H J, Lee J Y, et al. Marine algal fucoxanthin inhibits the metastatic potential of cancer cells[J]. Biochemical and biophysical research communications, 2013, 439(4): 580-585.
[6] Ye G, Wang L, Yang K, et al. Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D[J]. Journal of International Medical Research, 2020, 48(10): 0300060520964011.
[7] Shiratori K, Ohgami K, Ilieva I, et al. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo[J]. Experimental eye research, 2005, 81(4): 422-428.
[8] Yang H, Xing R, Liu S, et al. Role of Fucoxanthin towards Cadmium-induced renal impairment with the antioxidant and anti-lipid peroxide activities[J]. Bioengineered, 2021, 12(1): 7235-7247.
Fucoxanthin (all-trans-Fucoxanthin)是一种天然存在的类胡萝卜素,广泛分布于食用棕色海藻和硅藻中[1]。Fucoxanthin是高度不饱和的,其分子结构不稳定且非常活泼,Fucoxanthin有四种异构体,即all-trans Fucoxanthin(自然环境中的主要异构体)、9′-cis Fucoxanthin、13-cis Fucoxanthin、13′-cis Fucoxanthin[2]。Fucoxanthin能够用于肥胖症、抗糖尿病、抗氧化、炎症和癌症等研究[3]。Fucoxanthin能够有效抑制结核分枝杆菌芳香胺N-乙酰转移酶(TBNAT)活性,IC50值为4.8µM[4]。
在体外,Fucoxanthin(0-30μM)处理B16-F10细胞24h,以剂量依赖性方式抑制了细胞侵袭、迁移和粘附,抑制了转移因子MMP-9、CD44和CXCR4的表达[5]。Fucoxanthin(0-25µM)处理宫颈癌HeLa和SiHa细胞24h,抑制了细胞增殖,诱导了细胞周期停滞在G0/G1期[6]。Fucoxanthin(0-100µg/mL)处理RAW264.7细胞24h,以剂量依赖性方式抑制了细胞内TNF-α、PGE2、iNOS和COX-2蛋白的表达[7]。
在体内,Fucoxanthin(25, 50mg/kg)通过口服治疗氯化镉引起的肾脏损伤小鼠14天,促进了小鼠肾功能、肾细胞微结构组织和超微结构组织的恢复,显著降低了小鼠体内血尿素氮(BUN)、肾损伤分1(KIM1)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平,升高了过氧化物酶(POD)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和抗坏血酸过氧化物酶(APX)水平[8]。
Cell experiment [1]: | |
Cell lines | B16-F10 cells |
Preparation Method | 100μL of 0.2% collagen-fragmented gelatin was applied to the upper side of the filter. Serum-free DMEM (with or without Fucoxanthin (0, 5,10, 30μM)) was added to the lower part of the chamber. The chamber was incubated at 37°C in a 5% CO2 atmosphere for 24h. After incubation, the filter insert was removed from the chamber wells and cells on the upper side of the filter were removed using a cotton swab. The filter was fixed, stained with hematoxylin and eosin, and mounted on a microscope slide. Cells located on the lower side of the filter were counted to determine whether they were invasive cells. |
Reaction Conditions | 0, 5,10, 30μM; 24h |
Applications | Fucoxanthin resulted in a significant decrease in the number of invaded B16-F10 cells. |
Animal experiment [2]: | |
Animal models | Kunming mice |
Preparation Method | Total animals (N=120) were randomly divided into two groups of equal average body weight. The mice of the control group (N=20) were given pure water only, whereas the animals of the cadmium exposure group (N=100) were given CdCl2 orally at a dose of 30mg/kg/day for 30 days. In this study, Fucoxanthin was administered at 10, 25 and 50mg/kg/day. To evaluate ameliorative effects of Fucoxanthin on the kidney, the cadmium exposure group was divided into the following five subgroups: without Fucoxanthin treatment as a negative control group (NCG); positive control group (PCG) was mice received Shenfukang tablets orally at a dose of 50mg/kg/day for 14 days; low (F1), medium (F2), and high (F3) Fucoxanthin concentration treated mice were received Fucoxanthin orally at a dose of 10, 25, and 50mg/kg/day for 14 days, respectively. After the 14-day Fucoxanthin treatment, mice were sacrificed. Kidney tissues and peripheral blood samples were collected directly. |
Dosage form | 10, 25, 50mg/kg/day for 14 days; p.o. |
Applications | High doses of Fucoxanthin administration significantly decreased BUN, KIM1, NGAL levels, increasing POD, SOD, CAT, and ascorbate APX levels. Fucoxanthin administration also promoted recovery of the renal functions, micro-structural organization, and ultra-structural organization in the renal cells. |
References: |
Cas No. | 3351-86-8 | SDF | |
别名 | 岩藻黄质; all-trans-Fucoxanthin | ||
Canonical SMILES | O=C(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C([H])=[C@@]=C([C@@]1(O)C)C(C)(C[C@H](OC(C)=O)C1)C)C[C@]2(C3(C)C)[C@@](C)(C[C@@H](O)C3)O2 | ||
分子式 | C42H58O6 | 分子量 | 658.91 |
溶解度 | DMSO : ≥ 50 mg/mL (75.88 mM);Water : < 0.1 mg/mL (insoluble) | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.5177 mL | 7.5883 mL | 15.1766 mL |
5 mM | 0.3035 mL | 1.5177 mL | 3.0353 mL |
10 mM | 0.1518 mL | 0.7588 mL | 1.5177 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet